Literature DB >> 25332598

Precursor NK cell lymphoblastic leukemia/lymphoma-report of a case with literature review.

Sonal Jain1, Rajiv Kumar1, Abhishek Purohit1, Hara Prasad Pati1.   

Abstract

Precursor Natural Killer (NK) cell lymphoblastic leukemia/lymphoma is a rare entity defined clearly by WHO (2008 WHO classification). However, the pathobiology of this subset of neoplasms is not clearly defined. There is wide disparity in the literature regarding the nomenclature and diagnostic criteria used to diagnose and characterize acute leukemias of presumed NK cell origin. In the present article we report a case of Precursor NK cell lymphoblastic leukemia/lymphoma and review the cases reported after 2008 WHO classification came into vogue, as acute leukemias of NK cell origin.

Entities:  

Keywords:  Leukemia; Natural killer; Precursor

Year:  2014        PMID： 25332598      PMCID： PMC4192181          DOI： 10.1007/s12288-014-0360-x

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


  7 in total

1.  Five Chinese pediatric patients with leukemias possibly arising from immature natural killer cells: clinical features and courses.

Authors:  Xiao-Qing Guan; Ling Xu; Zhi-Yong Ke; Li-Bin Huang; Xiao-Li Zhang; Ying-Chuan Zhang; Xue-Qun Luo
Journal:  Pediatr Hematol Oncol       Date:  2011-01-27       Impact factor: 1.969

2.  The presence of CD56/CD16 in T-cell acute lymphoblastic leukaemia correlates with the expression of cytotoxic molecules and is associated with worse response to treatment.

Authors:  Leandro F F Dalmazzo; Rafael H Jácomo; André F Marinato; Lorena L Figueiredo-Pontes; Renato L G Cunha; Aglair B Garcia; Eduardo M Rego; Roberto P Falcão
Journal:  Br J Haematol       Date:  2008-11-11       Impact factor: 6.998

Review 3.  Myeloid/natural killer cell precursor acute leukemia with multiple subcutaneous nodules as the initial presentation: a case report and literature review.

Authors:  Yan Ma; Bobin Chen; Xiaoping Xu; Guowei Lin
Journal:  Int J Hematol       Date:  2009-07-30       Impact factor: 2.490

4.  Pediatric myeloid/NK cell precursor lymphoma/leukemia expressing T/NK immunophenotype markers.

Authors:  Yoshiko Hashii; Tokuko Okuda; Hideaki Ohta; Keiichi Ozono; Junichi Hara
Journal:  Int J Hematol       Date:  2010-02-10       Impact factor: 2.490

5.  The clinical characteristics of CD7+ CD56+ acute myeloid leukemias other than M0.

Authors:  Ritsuro Suzuki; Shigeki Ohtake; Jin Takeuchi; Masami Nagai; Yoshihisa Kodera; Motohiro Hamaguchi; Shuichi Miyawaki; Takahiro Karasuno; Shigetaka Shimodaira; Ryuzo Ohno; Shigeo Nakamura; Tomoki Naoe
Journal:  Int J Hematol       Date:  2010-01-29       Impact factor: 2.490

6.  Uncommon cases of immature-type CD56+ natural killer (NK)-cell neoplasms, characterized by expression of myeloid antigen of blastic NK-cell lymphoma.

Authors:  Satsuki Owatari; Maki Otsuka; Taketsugu Takeshita; Kyoko Mizukami; Sinsuke Suzuki; Kimiharu Uozumi; Yukie Tashiro; Naomichi Arima; Shuichi Hanada
Journal:  Int J Hematol       Date:  2008-12-25       Impact factor: 2.490

7.  Myeloid/NK cell acute leukemia.

Authors:  Bobin Chen; Xiaoping Xu; Meirong Ji; Guowei Lin
Journal:  Int J Hematol       Date:  2009-03-28       Impact factor: 2.490
  7 in total
  1 in total

1.  Natural Killer Cell Lymphoblastic Leukaemia/Lymphoma: Case Report and Review of the Recent Literature.

Authors:  Qanita Sedick; Sultan Alotaibi; Saeed Alshieban; Khalid Ben Naheet; Ghaleb Elyamany
Journal:  Case Rep Oncol       Date:  2017-07-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.